CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srivastava, A.
Right arrow Articles by Kreiger, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, A.
Right arrow Articles by Kreiger, N.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 49-54, January 2004
© 2004 American Association for Cancer Research

Cigarette Smoking and Testicular Cancer

Anil Srivastava1 and Nancy Kreiger1,2

1 Division of Preventive Oncology, Research Unit Cancer Care Ontario, Toronto, Ontario, and 2 Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada

The purpose of this study was to determine the relation between testicular cancer and cigarette smoking. Data were collected between 1995 and 1996 in Ontario, Canada, as part of the Enhanced Cancer Surveillance Study. Pack-years and years of smoking were examined among all subjects (212 cases and 252 controls) and former and current smokers. Years since quitting and age at smoking initiation were examined among former and current smokers only. Independent of smoking status, significant associations were noted among those who smoked between 12 and 24 pack-years [odds ratio (OR) = 1.96 (95% confidence interval (CI): 1.04–3.69), relative to nonsmokers] or greater [>24 pack-years, OR = 2.31 (95% CI: 1.12–4.77), relative to nonsmokers], and among those who smoked >21 years [OR = 3.18 (95% CI: 1.32–7.64), relative to nonsmokers]. Quitting smoking was not found to result in a reduction of risk. No association was observed for smoking at adolescence relative to a later period. Results from the study suggest that cigarette smoking exerts an adverse influence on testicular cancer risk that is not mitigated by smoking cessation and not altered by age at initiation.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Geyer, B. Doring, K. Meerkamp, B. Ugele, N. Bakhiya, C. F. Fernandes, J. R. Godoy, H. Glatt, and E. Petzinger
Cloning and Functional Characterization of Human Sodium-dependent Organic Anion Transporter (SLC10A6)
J. Biol. Chem., July 6, 2007; 282(27): 19728 - 19741.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.